Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.87 - $2.7 $34,073 - $49,196
-18,221 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$1.99 - $3.25 $14,604 - $23,851
7,339 Added 67.44%
18,221 $36,000
Q3 2020

Nov 16, 2020

BUY
$2.85 - $4.1 $31,013 - $44,616
10,882 New
10,882 $31,000

Others Institutions Holding CDTX

About Cidara Therapeutics, Inc.


  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $837M
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.